How to Read Clinical Trial Data

Reading clinical trial data comes down to three steps, in order: what was tested, in whom, and how; what changed, and compared with what; and how much confidence the results deserve. This guide walks through each step, explains the statistics you will see (p-values, confidence intervals, and effect sizes), and ends with a checklist for teams reviewing a study on their own product or a published study on an ingredient.

Along the way, it explains how clinical trial data analysis is done, from the statistical analysis plan to the final report, so marketing, R&D, and regulatory teams can tell a careful analysis from a weak one. If you are reading for yourself, the same checks help you make well-informed decisions about your health.

What Is Clinical Trial Data?

Clinical trial data refers to the information collected during a clinical study that evaluates the safety and efficacy of an intervention, such as a drug, device, supplement, or behavioral program. It may include:

• Participant demographics: Characteristics like age, gender, ethnicity, and health status.
• Efficacy measures: Primary and secondary endpoints used to assess how well an intervention works (e.g., deep sleep changes).
• Safety data: Adverse events or side effects experienced during the trial.
• Protocol details: Study design outlines, such as a decentralized clinical trial framework.

Analyzing these involves statistical methods to estimate how large an effect is and how confident you can be in it. Results are written up in a clinical study report and, for some studies, a peer-reviewed journal.

Why Is Understanding Clinical Trial Data Important?

How to Read Clinical Trial Data

1. Assess Credibility: Check study quality, peer review status, methodology, and funding sources.
2. Identify Study Design: Determine if it is a randomized controlled trial, cohort study, or case-control study.
3. Assess the Population: Examine demographics to see if results apply to your population of interest.
4. Evaluate the Intervention: Look at dosage, frequency, and duration compared to standard care.
5. Review the Endpoints: Identify the main outcomes measured, such as clinical markers or symptoms.
6. Analyze the Results: Gauge strength via effect sizes, confidence intervals, and p-values.
7. Consider Limitations: Look for small sample sizes or high dropout rates that may affect generalizability.
8. Interpret Conclusions: Be cautious of overstated claims that go beyond the scope of the actual data.

Understanding the Key Statistics

These four ideas cover most of what you will see in a results table. Together they make up the core of clinical study statistics.

Compared With What? Between-Group vs Within-Group Results

The most common mistake in reading a product study is treating a before-and-after change as the effect of the product. People often feel better over time for reasons unrelated to the product: placebo response, natural ups and downs in symptoms, seasonal changes, or simply getting used to being measured. In a controlled trial, the result that matters is the difference between the treatment group and the control group. A within-group change can be a useful signal, but it cannot show on its own that the product caused the change. This is also why a control group matters for claims.

Endpoints, Dropouts, and Other Details That Change the Story

• Primary endpoint first. The protocol should name one or a few primary endpoints before data collection. Secondary and exploratory results are supportive, and the more comparisons a study runs, the more likely one looks significant by chance.
• Subgroups. A finding in a subgroup identified after the fact is a lead for the next study, not a conclusion.
• Intention-to-treat vs per-protocol. Intention-to-treat analysis includes everyone as randomized, including people who stopped early. Per-protocol analysis includes only those who followed the protocol. Intention-to-treat is usually the more conservative view.
• Dropouts and missing data. Check how many people left, from which group, and how missing values were handled.
• Dose and duration. Was the study long enough for the outcome to change, and does the dose match the product being discussed?

Clinical Trial Data Analysis: How the Results Are Produced

Every number in a results section comes out of a process that starts long before the last participant finishes. Knowing that process makes it easier to spot a careful analysis, and to notice when steps were skipped. In plain terms, clinical trial statistical analysis estimates two things: how large the difference between groups is, and how much uncertainty surrounds it.

• Statistical analysis plan. A written plan names the primary endpoint, the comparisons, the statistical methods, and the rules for missing data. It should be set before the results are known, and ideally before enrollment starts.
• Analysis populations. The report should say which participants each analysis includes, such as everyone randomized (intention-to-treat) or only those who followed the protocol (per-protocol).
• Data cleaning. Values are checked for errors, out-of-range entries, and duplicates, and device, lab, and survey data are lined up by participant and date before analysis.
• The main comparison. Many controlled studies compare the change from baseline between groups, often adjusting for each participant's starting value. Repeated measurements, such as nightly wearable data, are usually analyzed with methods built for repeated measures rather than a single before-and-after average.
• Multiple comparisons. When a study tests many outcomes, the plan should explain how it limits false positives, for example by ranking endpoints in order of importance or adjusting the p-values.
• Sensitivity analyses. Extra analyses check whether the main result holds under different assumptions, such as other ways of handling missing data.

What Clinical Trial Analytics Adds During a Study

Clinical trial analytics usually refers to the reporting that runs while a study is live: enrollment against target, adherence, wearable wear time and syncing, survey completion, and data quality flags. These views help the study team fix problems early, before they turn into missing data. They are not the same as the final analysis. Looking at outcome results by group before the study ends can bias decisions, so any interim analysis should be planned in the protocol.

Reading Wearable and Survey Data

Wearable data adds many repeated measurements per participant, which is useful and easy to misread. Check which device and which metric was used (for example, total sleep time vs a proprietary composite score), how the baseline was set, the minimum wear-time rule, and how nights with missing data were treated. Also check whether results are averaged over the whole study or taken at set time points. For the tradeoffs of consumer wearables in research, see our pros and cons guide.

For surveys, look for established instruments, such as the PSQI for sleep or PROMIS scales, and ask whether participants knew which group they were in, since expectations can shape self-reported outcomes.

Ingredient Studies vs Studies on Your Product

Many brands cite research on an ingredient rather than on the finished product. Before relying on it, compare the dose and form, the population (age, health status), the study length, the endpoint that was measured vs the benefit you want to describe, and whether there was a placebo or other control. The more these differ, the weaker the link between that study and your product. Here is a step-by-step way to fact-check a supplement claim.

Our comparison of Google Scholar and PubMed covers the tools and resources for finding that research in the first place.

Tips for Reading Clinical Trial Papers

Start with the Abstract

The abstract provides a concise summary of objectives, methods, and results. It serves as a snapshot of the study's scope.

Focus on the Methods Section

This section details the study design, participant selection, and statistical analysis. Assessing these gives insight into the quality of the evidence.

Contextualize Results

Results should be interpreted within the framework of the design. While statistical significance suggests a result is unlikely to be due to chance alone, clinical significance relates to practical importance.

Look for Limitations and Bias

Acknowledgment of limitations helps define the applicability of findings. Be aware of selection or reporting biases to achieve a balanced interpretation.

Checklist: Reviewing a Study Report on Your Product

A complete clinical study report should include an executive summary, full methodology, statistical analysis with significance testing, aggregate and segmented results, and safety and adverse event reporting. When you review one, confirm:

• The primary endpoint and analysis plan were set before data collection
• The headline result is a between-group comparison, if the study had a control group
• All prespecified outcomes are reported, including ones that did not change
• The numbers enrolled, completed, and analyzed are all stated
• Adverse events are summarized
• The conclusion stays within what the data show

Reading data well is a skill that grows with practice. If you are planning a study and want results built to pass these checks, see how a full clinical study is designed and reported.

How Reputable Handles Clinical Trial Data

Reputable Health runs studies with one team from protocol to report: protocol design, IRB submission, enrollment, data capture, analysis, and reporting. Wearable, lab, and survey data are collected on protocol cadence and joined per participant into a single dataset. Studies can combine continuous wearables (including Oura, Apple Watch, and Whoop), at-home labs with blood biomarkers processed through CLIA-certified labs, and established surveys such as PROMIS and PSQI.

Full clinical studies use pre-registered statistical methodology with formal analysis and p-value reporting, and the analysis is statistician-reviewed. Daily check-ins and automated reminders keep adherence visible during the study, and the team shares progress and outcome updates at pivotal endpoints. Depending on the agreed scope, deliverables can include the clinical study report, a communications package with claim language guidance, and an anonymized participant-level dataset with a codebook, data dictionary, and analysis scripts. Teams that want an earlier read can start with a pilot study that looks for signal on a smaller scope.

Frequently Asked Questions